Apple (NASDAQ: AAPL) once again delivered disappointing product sales as it announced fourth-quarter earnings results on Wednesday. Revenue from Apple products fell 1.5% year-over-year to $51.5 billion.
iPhone net sales declined 9.2% in Q4 to $33.36 billion. The quarterly results included the initial 10-days’ sale of the latest iPhone models – iPhone 11, iPhone 11 Pro and iPhone 11 Pro Max – which were released last month.
The weakness its flagship product weighed on the overall revenues, which edged up 2% to $64 billion. However, this still came in above the street consensus of $63 billion. International sales accounted for 60% of the quarter’s revenue.
Earnings grew 4% to $3.03 per share, while analysts had projected it at $2.84 per share. The better-than-expected earnings sent AAPL shares up 1.5% during after-market trading on Tuesday.
Meanwhile, Apple’s services segment slightly offset the weakness in the products side with an 18% year-over-year growth to $12.5 billion, an all-time high.
CEO Tim Cook said, “With customers and reviewers raving about the new generation of iPhones, today’s debut of new, noise-cancelling AirPods Pro, the hotly-anticipated arrival of Apple TV+ just two days away, and our best lineup of products and services ever, we’re very optimistic about what the holiday quarter has in store.”
For the first quarter of 2019, the iPhone maker expects revenue between $85.5 billion and $89.5 billion. Gross margin is projected between 37.5% and 38.5%.
So far this year, AAPL stock has increased 53%, crowning it once again, earlier this month, the title of most valued public company in the world.
Philip Morris International Inc. (NYSE: PM) reported Third-quarter 2021 earnings results today. Net revenues increased 9% year-over-year to $8.1 billion. The reported net income amounted to $2.42 billion compared to
Halliburton (NYSE: HAL) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The company reported Q3 revenue of $3.9 billion, up 30% year-over-year and lower than the
Johnson & Johnson (NYSE: JNJ) reported third-quarter 2021 financial results before the regular market hours on Tuesday. The pharmaceutical giant reported revenue of $23.3 billion, up 10.7% year-over-year, with operational